If like many people here at the Health Matters Show, you suffer with Fibromyalgia, the subject of pain management is important to you. Here’s a good (yet brief) resource/ research report I found with news on the drug, Milnacipran.
It seems to be gaining in popularity and acceptance, as a pharmaceutical drug that is effective for central pain processing problems.
‘Milnacipran is an SNRI that has been approved for the management of FM (Fibromyalgia). In clinical trials, treatment with milnacipran for up to 1 year has been found to improve the pain and other symptoms of FM.’
Now this is good news for those Fibromyalgia folks looking for immediate help with chronic pain and central pain processing problems, but I have to wonder, what happens at the end of that first year? Does it lessen in effectiveness? Do you have to stop it? Can you restart to take the drug after a period of time? Did it cause you to have uncomfortable or nasty side effects?
Now… the concept of central pain processing is gaining more and more publicity as an important factor in Fibromyalgia and chronic pain conditions. It’s not a new idea by any means, but it keeps coming up and that means that there is more research being done investigating it. (Here’s an older article.) Plus, now with the introduction of Milnacipran, there’s a drug to help you manage the underlying, body abnormality that researchers call central pain processing problems.
If you have personal experience with taking Milnacipran, please comment here and share your thoughts about how it did or did not affect your pain symptoms.
Thanks, Cinda Crawford
Host of the Health Matters Show
{ 1 trackback }
{ 1 comment… read it below or add one }
Carole Shaver 05.31.10 at 7:03 am
If I had a dime for each time I came to healthmattershow.com… Great post.